My bookmarksSign up free
Source

Commission Implementing Regulation (EU) 2023/1108 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘OP Plus’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

Commission Implementing Regulation (EU) 2023/1108 of 6 June 2023 granting a Union authorisation for the single biocidal product ‘OP Plus’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)

Implementing Regulation (EU) 2023/1108 · Regulation · 3 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

A Union authorisation with authorisation number EU-0027670-0000 is granted to Laboratorium Dr. Deppe GmbH for the making available on the market and use of the same single biocidal product ‘OP Plus’ in accordance with the summary of the biocidal product characteristics set out in the Annex. The Union authorisation is valid from 27 June 2023 until 31 July 2032.

Article 2

Open ↗

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open ↗

ANNEX Summary of product characteristics for a biocidal product OP Plus Product type 1 - Human hygiene (Disinfectants) Authorisation number: EU-0027670-0000 R4BP asset number: EU-0027670-0000 1.    ADMINISTRATIVE INFORMATION 1.1.    Trade name(s) of the product Trade name(s) OP Plus Nextsept MyClean HB plus MyClean HB basic Bavicid Hand 1.2.    Authorisation holder Name and address of the authorisation holder Name Laboratorium Dr. Deppe GmbH Address Hooghe Weg 35, 47906 Kempen Germany Authorisation number EU-0027670-0000 R4BP asset number EU-0027670-0000 Date of the authorisation 27 June 2023 Expiry date of the authorisation 31 July 2032 1.3.    Manufacturer(s) of the product Name of manufacturer Laboratorium Dr. Deppe GmbH Address of manufacturer Hooghe Weg 35, 47906 Kempen Germany Location of manufacturing sites Laboratorium Dr. Deppe GmbH, Hooghe Weg 35, 47906 Kempen Germany 1.4.    Manufacturer(s) of the active substance(s) Active substance Propan-1-ol Name of manufacturer OQ Chemicals GmbH (formerly Oxea GmbH) Address of manufacturer Rheinpromenade 4a, 40789 Monheim am Rhein Germany Location of manufacturing sites OQ Chemicals Corperation (formerly Oxea Coperation), 2001 FM 3057 TX, 77414 Bay City United States Active substance Propan-1-ol Name of manufacturer BASF SE Address of manufacturer Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany Location of manufacturing sites BASF SE, Carl-Bosch-Str. 38, 67056 Ludwigshafen Germany Active substance Propan-1-ol Name of manufacturer SASOL Chemie GmbH & Co. KG Address of manufacturer Secunda Chemical Operations, Sasol Place, 50 Katherine Street, 2090 Sandton South Africa Location of manufacturing sites Secunda Chemical Operations, PDP Kruger Street, 2302 Secunda South Africa Active substance Propan-2-ol Name of manufacturer Stockmeier Chemie GmbH & Co. KG Address of manufacturer Am Stadtholz 37, 33609 Bielefeld Germany Location of manufacturing sites INEOS Solvent Germany GmbH, Römerstrasse 733, 47443 Moers Germany Active substance Propan-2-ol Name of manufacturer Brenntag GmbH Address of manufacturer Stinnes-Platz 1, 45472 Mülheim an der Ruhr Germany Location of manufacturing sites Shell Nederland Raffinaderij B.V., 3196 KK Rotterdam-Pernis Netherlands Exxon Mobil, LA 70805 Baton Rouge United States 2.    PRODUCT COMPOSITION AND FORMULATION 2.1.    Qualitative and quantitative information on the composition of the product Common name IUPAC name Function CAS number EC number Content (%) Propan-1-ol   Active Substance 71-23-8 200-746-9 12,229 Propan-2-ol   Active Substance 67-63-0 200-661-7 62,751 2.2.    Type of formulation AL - Any other liquid 3.    HAZARD AND PRECAUTIONARY STATEMENTS Hazard statements Highly flammable liquid and vapour. Causes serious eye damage. May cause drowsiness or dizziness. Repeated exposure may cause skin dryness or cracking. Precautionary statements Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. - No smoking. Keep container tightly closed. Avoid breathing vapours. Use only outdoors or in a well-ventilated area. IF INHALED:Remove person to fresh air and keep comfortable for breathing. IF IN EYES:Rinse cautiously with water for several minutes.Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. Store in a well-ventilated place.Keep cool. Store locked up. Dispose of container to an authorised waste collection point. 4.    AUTHORISED USE(S) 4.1.    Use description Table 1. Use # 1 – hygienic handrub, liquid Product type PT01 - Human hygiene (Disinfectants) Where relevant, an exact description of the authorised use Not relevant Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Tuberculosis bacilli Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: Enveloped viruses Development stage: no data Field(s) of use Indoor — hospitals and other health care institutions, ambulances, surgeries, nursing homes (including home-care of patients) — hospital canteens, large kitchens, pharmaceutical industries, production sites, laboratories: hygienic handrub onto visibly clean and dry hands — For professional use only. Application method(s) Method: Manual application Detailed description: Rubbing Application rate(s) and frequency Application Rate: Dosage: At least 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml). Contact time: 30 s Dilution (%): Ready-to-use product Number and timing of application: There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases. The product may be used at any time and as often as required. Category(ies) of users Industrial Professional Pack sizes and packaging material 100, 125, 150, 500, 1 000 ml in white HDPE bottles with PP flip top caps; 5 000 ml white HDPE canister with HDPE screwed cap. 4.1.1.    Use-specific instructions for use The products can be applied directly or the products can be used in a dispenser or with a pump. For hygienic handrub use 3 ml of product and keep hands wet for 30 seconds. Do not refill. 4.1.2.    Use-specific risk mitigation measures See general directions for use 4.1.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.1.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.1.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 4.2.    Use description Table 2. Use # 2 – surgical handrub, liquid Product type PT01 - Human hygiene (Disinfectants) Where relevant, an exact description of the authorised use Not relevant. Target organism(s) (including development stage) Scientific name: no data Common name: Bacteria Development stage: no data Scientific name: no data Common name: Tuberculosis bacilli Development stage: no data Scientific name: no data Common name: Yeasts Development stage: no data Scientific name: no data Common name: enveloped viruses Development stage: no data Field(s) of use Indoor Hospitals and other health care institutions: surgical handrub onto visibly clean and dry hands and forearms. For professional use only. Application method(s) Method: Manual application Detailed description: Rubbing Application rate(s) and frequency Application Rate: Dosage: Rub sufficient amount in portions of 3 ml (use dispensers: for example set to 1,5 ml per stroke, 2 strokes per 3 ml). Contact time: 90 s Dilution (%): Ready-to-use product Number and timing of application: There is no restriction in the number and timing of applications. No safety intervals need to be considered between the application phases. The product may be used at any time and as often as required. Category(ies) of users Professional Pack sizes and packaging material 100, 125, 150, 500, 1 000 ml in white HDPE bottles with PP flip top caps; 5 000 ml white HDPE canister with HDPE screwed cap. 4.2.1.    Use-specific instructions for use The products can be applied directly or the products can be used in a dispenser or with a pump. For surgical handrub use as many portions of 3 ml as necessary to keep hands wet for 90 seconds. Do not refill. 4.2.2.    Use-specific risk mitigation measures See general directions for use 4.2.3.    Where specific to the use, the particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment See general directions for use 4.2.4.    Where specific to the use, the instructions for safe disposal of the product and its packaging See general directions for use 4.2.5.    Where specific to the use, the conditions of storage and shelf-life of the product under normal conditions of storage See general directions for use 5.    GENERAL DIRECTIONS FOR USE   ( 1 ) 5.1.    Instructions for use For professional use only. 5.2.    Risk mitigation measures Avoid contact with eyes. Keep out of reach of children. 5.3.    Particulars of likely direct or indirect effects, first aid instructions and emergency measures to protect the environment First-aid measures general: Move the affected person away from the contaminated area. Get medical advice/attention if you feel unwell. If possible, show this sheet. IF INHALED: Move to fresh air and keep at rest in a position comfortable for breathing. Call a POISON CENTRE or a doctor. IF ON SKIN: Immediately wash skin with plenty of water. Thereafter take off all contaminated clothing and wash it before reuse. Continue to wash the skin with water for 15 minutes. Call a POISON CENTRE or a doctor. IF IN EYES: Immediately rinse with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing for at least 15 minutes. Call 112/ambulance for medical assistance. Information to Healthcare personnel/doctor: The eyes should also be rinsed repeatedly on the way to the doctor if eye exposure to alkaline chemicals (pH > 11), amines and acids like acetic acid, formic acid or propionic acid. IF SWALLOWED: Immediately rinse mouth. Give something to drink, if exposed person is able to swallow. Do NOT induce vomiting. Call 112/ambulance for medical assistance. Accidental release measures: Stop leak if safe to do so. Remove ignition sources. Use special care to avoid static electric charges. No open flames. No smoking. Prevent entry to sewers and public waters. Wipe up with absorbent material (for example cloth). Soak up spills with inert solids, such as clay or diatomaceous earth as soon as possible. Take up mechanically (sweeping, shovelling). Dispose of in accordance with relevant local regulations. 5.4.    Instructions for safe disposal of the product and its packaging Disposal must be done according to official regulations. Do not empty into drains. Do not dispose of with domestic waste. Dispose of contents/container to an authorised waste collection point. Empty the packaging completely prior to disposal. When totally empty, containers are recyclable like any other packing. 5.5.    Conditions of storage and shelf-life of the product under normal conditions of storage Shelf-life: 24 months Store in dry, cool, well-ventilated area. Keep container tightly closed. Keep out of direct sunlight. Recommended storage temperature: 0-30°C Do not store at temperatures below 0°C Do not store near food, drink and animal feedingstuff. Keep away from combustible material. 6.    OTHER INFORMATION ( 1 )   Instructions for use, risk mitigation measures and other directions for use under this section are valid for any authorised uses.

Other acts of the same type
Commission Regulation (EU) 2020/2008 of 8 December 2020 amending Regulations (EU) No 702/2014, (EU) No 717/2014 and (EU) No 1388/2014, as regards their period of application and other relevant adjustments (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/2079 of 8 December 2020 approving amendments to the product specification for a spirit drink whose name is registered as a geographical indication (Münchener Kümmel)Council Regulation (EU) 2020/1998 of 7 December 2020 concerning restrictive measures against serious human rights violations and abusesCommission Implementing Regulation (EU) 2020/2002 of 7 December 2020 laying down rules for the application of Regulation (EU) 2016/429 of the European Parliament and of the Council with regard to Union notification and Union reporting of listed diseases, to formats and procedures for submission and reporting of Union surveillance programmes and of eradication programmes and for application for recognition of disease-free status, and to the computerised information system (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/2003 of 7 December 2020 amending Council Regulation (EC) No 1210/2003 concerning certain specific restrictions on economic and financial relations with IraqCommission Implementing Regulation (EU) 2020/2035 of 7 December 2020 amending Implementing Regulation (EU) No 1352/2013 as regards the application for action form provided for in Regulation (EU) No 608/2013 of the European Parliament and of the Council, in order to introduce the possibility to request the taking of action in Northern IrelandCommission Delegated Regulation (EU) 2020/2192 of 7 December 2020 amending Annex II to Regulation (EC) No 853/2004 of the European Parliament and of the Council as regards the identification mark to be used for certain products of animal origin in the United Kingdom in respect of Northern Ireland (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/37 of 7 December 2020 on amending Delegated Regulation (EU) 2016/1675 supplementing Directive (EU) 2015/849 of the European Parliament and of the Council, as regards deleting Mongolia from the table in point I of the Annex (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/234 of 7 December 2020 amending Delegated Regulation (EU) 2015/2446 as regards common data requirements, and Delegated Regulation (EU) 2016/341 as regards the codes to be used in certain formsCommission Implementing Regulation (EU) 2020/1993 of 4 December 2020 authorising the placing on the market of selenium-containing yeast (Yarrowia lipolytica) biomass as a novel food under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2020/1995 of 4 December 2020 amending Implementing Regulation (EU) No 2018/1261 as regards administrative changes of the information related to the Union authorisation of the biocidal product family ‘Hypred’s iodine based products’ (Text with EEA relevance)Commission Delegated Regulation (EU) 2021/139 of 4 December 2020 amending Annexes I and V to Regulation (EU) 2019/125 concerning trade in certain goods which could be used for capital punishment, torture or other cruel, inhuman or degrading treatment or punishment to take into account the withdrawal of the United Kingdom from the Union

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next